Medtronic launches a clinical trial of its Endurant Evo stent graft for treating abdominal aortic aneurysms.
Medtronic (NYSE:MDT) today said it launched a clinical trial of its Endurant Evo stent graft for treating abdominal aortic aneurysms.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Ifiaoe
Cap comentari:
Publica un comentari a l'entrada